This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
(Reuters) - Intercontinental Exchange on Tuesday said it would launch a crude oil futures contract deliverable in Houston later this quarter, capitalizing on the growth in U.S. exports of crude oil that have risen to about 2 million barrels a day.
Investors looking for stocks in the Oil and Gas - Production Pipeline - MLB sector might want to consider either Plains All American Pipeline (PAA - Free Report) or Magellan Midstream Partners (MMP - Free Report) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.
Energy producers have flocked to the prolific Permian Basin boosting demand for takeaway capacity and creating serious bottlenecks.
ETP.PRC DCP CJ XEC KMI.WS CRLFF DVN REN PE CXO SCAZP EPD ENB MPC ANDV AXAS CRZO AREX KMI.PRA KMI RSPP PAA MMP JAG SNZYP KMR CVB SN CDEV NBL MTDR SM BWP HKRCP DCP.PRB HK.WS ESTE PSXP SRE.PRA ETP DPM SRE CVX LPI HK TRGP KMRFZ
HOUSTON (Bloomberg) -- The pipeline crunch threatening the world’s hottest shale play won’t be solved until at least the back half of next year. But then, the floodgates will open.
ETP.PRC ETP MMP PAA
In a rising broad market and a mixed commodity price backdrop, midstream stocks traded up but lagged the S&P 500 and utilities this week. Recent midstream corporation and utility outperformance has helped the Alerian Energy Infrastructure Index (AMEI) cut into the YTD lead the Alerian MLP Index has maintained since the MLP spike in January.
BKEP TGE PAGP SMLP ENB KEY IPL TEP BPL TEGP CEQP NSH OKE.WI EBBNF OKE BIP MMP IPPLF ENBBF BWP NS.PRC ENB NS.PRB PPL SEMG NS NS.PRA
June was another strong month for dividends and the second quarter gave me the highest dividend payments by far since I started tracking that.
SOJA MTSI C.WSA O.PRF OPRF WMT BAC C.WS.B C.WS.A C.PRP C.PRU MMP C.PRS SO BAC C C.PRL C.PRJ C.PRK O C.PRG C.PRC PEP C.PRPCL CGBBW IFF
Bullous pemphigoid is a disease with high unmet medical needs, no FDA-approved drug(s) and a one-year mortality of 10-30% following diagnosis due to limited therapeutic options.
IMNP BP MMP
The following slide deck was published by Magellan Midstream Partners, L.P. in conjunction with this event.
Enterprise Products Partners (EPD) is a master limited partnership (‘MLP’) with a focus on natural gas and natural gas liquids. They have earned a reputation for being a blue chip MLP due to their history of consistent and generous distribution increases in addition to a strong balance sheet. Shares trade at a 5.8% yield in spite of a recent run up in price. Still, future growth is almost certain to be nothing like the past - what does this mean for their distribution? I analyze the key metric for EPD and give my verdict on shares.
BHI EPD MMP
15h - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
17h - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to MMP / Magellan Midstream Partners, L.P. on message board site Silicon Investor.
|Modem Media . Poppe Tyson (Nasdaq: MMPT)||MMPT: Modem Media, Inc.|
|Macdonald Mines||MAXIM PHARMACEUTICALS (MMP)|
as of ET